Miaoting Yang

机构：ShenZhen People’s Hospital

发表论文 9 篇 · 总被引 269 次 · h-index 6

代表论文

• Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High‐Fat‐Diet‐Induced Nonalcoholic Fatty Liver Disease (2018 · Oxidative Medicine and Cellular Longevity · 被引 162)
• Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury (2017 · Frontiers in Pharmacology · 被引 36)
• Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats (2017 · Journal of Ethnopharmacology · 被引 30)
• Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways (2024 · BMC Complementary Medicine and Therapies · 被引 16)
• Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ (2020 · BMC Complementary Medicine and Therapies · 被引 11)
• Ultra-high performance liquid chromatography/triple quadrupole mass spectrometry study of the stabilities and transformations of four alisols in Alismatis Rhizoma and proprietary traditional Chinese medicine prescriptions (2018 · Pharmacognosy Magazine · 被引 11)